InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,842.47
(
0.47%
)
US TECH 100
19,608.00
(
-0.13%
)
Dow Jones
43,077.70
(
0.79%
)
Brent Oil
74.36
(
0.18%
)
Bitcoin
67,751.02
(
0.19%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bocxman

Send PM Follow Ignore
Followers 2
Posts 1054
Boards Moderated 0
Alias Born 03/03/2005

bocxman

Re: Gold Seeker post# 4913

Monday, 08/14/2006 11:31:38 AM

Monday, August 14, 2006 11:31:38 AM

Post# of 30387
seeker: by your logic, with Moro "giving RECAF away to ABT without any DD at all", ABT could have easily demanded an exclusive at the same price. your argument holds no water. RECAF may or may not succeed as a cancer marker, but claiming that ABT didn't do any DD conflicts with:

1) ABT's historical pattern of licensing cancer markers *VERY* selectively (2 in the past 18 months)

2) the time it took BOCX to get the deal, which was at least a year base down the PR and filing history where BOCX kept saying over and over "we're very close to signing a licensing deal with a major pharma"

get lost please.

DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up